DK0651609T3 - Pasteurella multocida toxoidvacciner - Google Patents

Pasteurella multocida toxoidvacciner

Info

Publication number
DK0651609T3
DK0651609T3 DK91913518T DK91913518T DK0651609T3 DK 0651609 T3 DK0651609 T3 DK 0651609T3 DK 91913518 T DK91913518 T DK 91913518T DK 91913518 T DK91913518 T DK 91913518T DK 0651609 T3 DK0651609 T3 DK 0651609T3
Authority
DK
Denmark
Prior art keywords
pasteurella multocida
multocida
methods
toxoid vaccines
vaccines
Prior art date
Application number
DK91913518T
Other languages
English (en)
Inventor
Joseph C Frantz
David S Roberts
Leroy A Swearingin
Richard J Kemmy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0651609T3 publication Critical patent/DK0651609T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK91913518T 1990-06-13 1991-06-10 Pasteurella multocida toxoidvacciner DK0651609T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53745490A 1990-06-13 1990-06-13
PCT/US1991/004092 WO1991019419A1 (en) 1990-06-13 1991-06-10 Pasteurella multocida toxoid vaccines

Publications (1)

Publication Number Publication Date
DK0651609T3 true DK0651609T3 (da) 1999-12-06

Family

ID=24142703

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91913518T DK0651609T3 (da) 1990-06-13 1991-06-10 Pasteurella multocida toxoidvacciner

Country Status (10)

Country Link
US (1) US5536496A (da)
EP (1) EP0651609B1 (da)
JP (1) JP3178720B2 (da)
AT (1) ATE183202T1 (da)
AU (2) AU8195391A (da)
DE (1) DE69131525T2 (da)
DK (1) DK0651609T3 (da)
ES (1) ES2136064T3 (da)
GR (1) GR3031487T3 (da)
WO (1) WO1991019419A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616328A (en) * 1991-11-15 1997-04-01 Pfizer Inc. Method of preparing gram-negative bacterial vaccines
CA2123320A1 (en) * 1991-11-15 1993-05-27 Joseph C. Frantz Pasteurella multocida toxoid vaccines
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
CA2192165A1 (en) * 1994-06-10 1995-12-21 Toru Kawai Process for purifying necrotoxin produced by bordetella and toxoid
US7626017B2 (en) * 1997-10-31 2009-12-01 Pressure Biosciences, Inc. Pressure-enhanced extraction and purification
AU4078699A (en) * 1998-05-15 1999-12-06 Mkb Investments Limited Partnership Compositions and method for immunizing poultry
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US6517844B1 (en) * 1999-05-14 2003-02-11 Marshall K. Brinton Compositions and method for immunizing polutry
MY128159A (en) * 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
WO2019023674A1 (en) * 2017-07-28 2019-01-31 Mccabe James G MULTIPURPOSE VENOUS VACCINES
US11446367B2 (en) * 2017-07-28 2022-09-20 Zootoxins, Llc Immunization with polyvalent venom vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine

Also Published As

Publication number Publication date
EP0651609B1 (en) 1999-08-11
AU8195391A (en) 1992-01-07
ES2136064T3 (es) 1999-11-16
JP3178720B2 (ja) 2001-06-25
ATE183202T1 (de) 1999-08-15
DE69131525D1 (de) 1999-09-16
EP0651609A4 (en) 1993-06-30
GR3031487T3 (en) 2000-01-31
EP0651609A1 (en) 1995-05-10
US5536496A (en) 1996-07-16
AU1362895A (en) 1995-08-10
AU685569B2 (en) 1998-01-22
DE69131525T2 (de) 1999-11-25
WO1991019419A1 (en) 1991-12-26
JPH05508407A (ja) 1993-11-25

Similar Documents

Publication Publication Date Title
ATE262924T1 (de) Streptokokken c5a peptidase impfstoff
ATE199644T1 (de) Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe
CA2089552A1 (en) Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof
LU91595I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
NO930938L (no) Forbedrede vaksiner
CY1106983T1 (el) ΕΜΒΟΛΙΟ ΠΕΠΤΙΔΑΣΗΣ C5a ΣΤΡΕΠΤΟΚΟΚΚΟΥ
DK0651609T3 (da) Pasteurella multocida toxoidvacciner
DK22389A (da) Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma
DE69113991D1 (de) Impfstoff.
EP0529019A4 (en) Nematode vaccine
CA2086258A1 (en) Pasteurella multocida toxoid vaccines
CA2312296A1 (en) Pasteurella multocida toxoid vaccines
DK0603386T3 (da) Parenteral immunisering mod rotavirus
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
NL7810753A (nl) Gecombineerd vaccin voor immunisering tegen infecties door haemophilus influenza, type b.
IT8722791A0 (it) Attenuato cosi' ottenuto. procedimento per la preparazione di un ceppo mutante migliorato di bordetella bronchiseptica utile per un vaccino attenuato vivo per la protezione da infezioni di b.bronchiseptica e vaccino ar vivo
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
RU93005000A (ru) Композиция вакцин, способ ее получения, способ исключения иммунной реакции
MX9604262A (es) Antigenos de pasteurellaceae y vacunas relacionadas.